http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103420977-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b3435dac1b5b74b23c2ba48e1ac36a9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444
filingDate 2013-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4798d42585926e735b0c3f188d6efd2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0c51a2b612a6215d04bec950e42e624
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70cc4c9d171d5653dcdecc4d5434a42c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0376522c21eb8c37c4ffd844d6ba0703
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9364c54fbf71c750d50ca281bf2ee197
publicationDate 2013-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103420977-A
titleOfInvention Acetylene derivatives with antitumor activity
abstract The present invention relates to an aromatic ring disubstituted acetylene derivative having general formula I, a pharmaceutical composition comprising the compound, and the use of the compound and the pharmaceutical composition for treating and/or preventing tumors, wherein A, B, T, M , Ra, Rb, Rt, m, n and p are as defined herein.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114533879-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114533879-B
priorityDate 2012-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012139027-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007075896-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012173521-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164101471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466747131
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID249771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415902910
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465940695

Total number of triples: 37.